Lemaitre Vascular (LMAT) Cash from Financing Activities (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Cash from Financing Activities data on file, last reported at -$3.2 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 38.56% year-over-year to -$3.2 million in Q1 2026; TTM through Mar 2026 was -$12.5 million, a 108.19% decrease from a year earlier, with the FY2025 full-year figure at -$14.5 million, down 109.2% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$3.2 million, up from -$3.6 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for LMAT reached as high as $164.1 million in Q4 2024 and fell as low as -$5.2 million in Q1 2025.
• Historically, Cash from Financing Activities has averaged $7.3 million across 5 years, with a median of -$2.7 million in 2023.
• Across the five-year window, Cash from Financing Activities jumped 6208.75% in 2024 and plunged 13533.33% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$2.1 million in 2022, then declined by 26.58% to -$2.7 million in 2023, then soared by 6208.75% to $164.1 million in 2024, then slumped by 102.19% to -$3.6 million in 2025, then gained by 10.26% to -$3.2 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$3.2 million in Q1 2026, -$3.6 million in Q4 2025, and -$2.9 million in Q3 2025.